Dr. Chinai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis Street
Boston, MA 02115
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2021- Brigham and Women's HospitalResidency, Internal Medicine, 2019
Albert Einstein College of MedicineClass of 2019, MD, PhD
Certifications & Licensure
MA State Medical License 2019 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 49 citationsKIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic targetYao Wei, Xiaoxin Ren, Phillip M. Galbo, Scott Moerdler, Hao Wang
Science Immunology. 2021-07-09 - 81 citationsHHLA2, a new immune checkpoint member of the B7 family, is widely expressed in human lung cancer and associated with EGFR mutational statusHaiying Cheng, Murali Janakiram, Alain C. Borczuk, Juan Lin, Wanglong Qiu
Clinical Cancer Research. 2017-02-01 - 69 citationsHHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survivalPratistha Koirala, Michael Roth, Jonathan Gill, Jordan M. Chinai, Michelle Ewart
Scientific Reports. 2016-08-17
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
